Trial intelligence / Profile preview

PedIMOD: Immune Response in Pediatric Multi-Organ Dysfunction

NCT04438460Completed

Sponsor
Hospices Civils de Lyon
Start
Jul 2020
Primary completion
Apr 2024
Countries
1
01

Overview

Open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Secondary acquired infection (SAI) at Day 60. Started Jul 2020; status: completed.

Beyond the preview

Go deeper on NCT04438460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04438460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call